People taking GLP-1s experienced a much slower rise in their blood alcohol levels, and felt the effects of alcohol (the good, the bad, the nauseating, and even whether or not they liked the drink) later on and with less intensity than those not on GLP-1 drugs
People with obesity have long struggled to control their weight, and new medications, including semaglutide and others, have been game changers for many, said Colin Banas, M.D., M.H.A., chief medical officer for DrFirst
These agents include thiazolidinediones (PPAR- agonists), dipeptidyl peptidase-4 (DPP-4) inhibitors, sulfonylureas, sodium-glucose co-transporter 2 (SGLT2) inhibitors, -glucosidase inhibitors, and glucagon-like peptide-1 (GLP-1) receptor agonists
None of these considerations should be read as guidance for use